Close Menu

cell-based assays

NEW YORK (GenomeWeb News) – French cell-based assays developer Cytoo said this week that it has raised $10 million in a Series C financing round.

NEW YORK (GenomeWeb News) – The Korean operations of Institut Pasteur and Sanofi-Aventis announced on Wednesday a collaboration to screen for new compounds directed at Hepatitis B.

NEW YORK (GenomeWeb News) – SwitchGear Genomics today said it has partnered with New England Biolabs to develop a new dual reporter assay system.

French life science firm Cytoo announced today that it, Cellectis Bioresearch, and the French Alternative Energies and Atomic Energy Commission (CEA) are partnering to develop cell-based assays for drug development and toxicology.

NEW YORK (GenomeWeb News) – Promega today announced that it has inked an alliance with Puracyp, under which the firms are combining their cell line and assay technologies in an offering to researchers.

NEW YORK (GenomeWeb News) – EMD Millipore today announced that it has signed an agreement to acquire Seattle-based Amnis, a developer and manufacturer of high-speed cellular imaging instruments.

The German startup is developing T-cell-based diagnostics and also provides cell-based assay testing for pharmaceuticals.

Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear.

As other regulatory agencies worldwide approve the assay, Allergan estimates that the use of animal-based testing for Botox products could be reduced by up to 95 percent or more during the next three years.

Pages

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.